Literature DB >> 25091674

Hospital based surveillance and genetic characterization of rotavirus strains in children (<5 years) with acute gastroenteritis in Kolkata, India, revealed resurgence of G9 and G2 genotypes during 2011-2013.

Satarupa Mullick1, Paulami Mandal1, Mukti Kant Nayak1, Souvik Ghosh2, Papiya De1, K Rajendran1, Mihir K Bhattacharya1, Utpala Mitra1, Thandavarayan Ramamurthy1, Nobumichi Kobayashi2, Mamta Chawla-Sarkar3.   

Abstract

INTRODUCTION: India accounts for an estimated 457,000-884,000 hospitalizations and 2 million outpatient visits for diarrhea. In spite of the huge burden of rotavirus (RV) disease, RV vaccines have not been introduced in national immunization programme of India. Therefore, continuous surveillance for prevalence and monitoring of the circulating genotypes is needed to assess the disease burden prior to introduction of vaccines in this region.
METHODS: During January 2011 through December 2013, 830 and 1000 stool samples were collected from hospitalized and out-patient department (OPD) patients, respectively, in two hospitals in Kolkata, Eastern India. After primary screening, the G-P typing was done by multiplex semi-nested PCR using type specific primers followed by sequencing. Phylogenetic analysis for the VP7 gene of 25 representative strains was done.
RESULTS: Among hospitalized and OPD patients, 53.4% and 47.5% cases were positive for rotaviruses, respectively. Unlike previous studies where G1 was predominant, in hospitalized cases G9 rotavirus strains were most prevalent (40%), followed by G2 (39.6%) whereas G1 and G12 occurred at 16.4% and 5.6% frequency. In OPD cases, the most prevalent strain was G2 (40.3%), followed by G1, G9 and G12 at 25.5%, 22.8%, 9.3%, respectively. Phylogenetically the G1, G2 and G9 strains from Kolkata did not cluster with corresponding genotypes of Rotarix, RotaTeq and Rotavac (116E) vaccine strains.
CONCLUSION: The study highlights the high prevalence of RV in children with gastroenteritis in Kolkata. The circulating genotypes have changed over the time with predominance of G9 and G2 strains during 2011-2013. The current G2, G9 and G1 Kolkata strains shared low amino acid homologies with current vaccine strains. Although there is substantial evidence for cross protection of vaccines against a variety of strains, still the strain variation should be monitored post vaccine introduction to determine if it has any impact on vaccine effectiveness.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Diarrhea; G2 strains; G9 strains; India; Kolkata; Rotavirus

Mesh:

Substances:

Year:  2014        PMID: 25091674     DOI: 10.1016/j.vaccine.2014.03.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Epidemiological studies on gastroenteritis in children in the Bannu district, Khyber Pakhtunkhwa, Pakistan.

Authors:  Muhammad Ashraf Khan
Journal:  Z Gesundh Wiss       Date:  2021-05-21

2.  Community based case-control study of rotavirus gastroenteritis among young children during 2008-2010 reveals vast genetic diversity and increased prevalence of G9 strains in Kolkata.

Authors:  Satarupa Mullick; Anupam Mukherjee; Santanu Ghosh; Gururaja P Pazhani; Dipika Sur; Byomkesh Manna; James P Nataro; Myron M Levine; Thandavarayan Ramamurthy; Mamta Chawla-Sarkar
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

3.  Whole genomic analysis of G2P[4] human Rotaviruses in Mymensingh, north-central Bangladesh.

Authors:  Satoru Aida; Samsoon Nahar; Shyamal Kumar Paul; Muhammad Akram Hossain; Muhammad Rashidul Kabir; Santana Rani Sarkar; Salma Ahmed; Souvik Ghosh; Noriko Urushibara; Mitsuyo Kawaguchiya; Meiji Soe Aung; Ayako Sumi; Nobumichi Kobayashi
Journal:  Heliyon       Date:  2016-10-01

4.  Rotavirus vaccine impact assessment surveillance in India: protocol and methods.

Authors:  Nayana P Nair; Samarasimha Reddy N; Sidhartha Giri; Venkata Raghava Mohan; Umesh Parashar; Jacqueline Tate; Minesh Pradyuman Shah; Rashmi Arora; Mohan Gupte; Sanjay M Mehendale; Gagandeep Kang
Journal:  BMJ Open       Date:  2019-04-25       Impact factor: 2.692

5.  10-Year Rotavirus Infection Surveillance: Epidemiological Trends in the Pediatric Population of Perugia Province.

Authors:  Chiara de Waure; Laura Sarnari; Manuela Chiavarini; Giovanni Ianiro; Marina Monini; Anna Alunno; Barbara Camilloni
Journal:  Int J Environ Res Public Health       Date:  2020-02-05       Impact factor: 3.390

6.  Burden and Molecular Epidemiology of Rotavirus Causing Diarrhea among Under-Five Children: A Hospital-based Study from Eastern India.

Authors:  Arpit Kumar Shrivastava; N Samarasimha Reddy; Sidhartha Giri; Priyadarshi Soumyaranjan Sahu; Mirabai Das; Nirmal Kumar Mohakud; Rashmi Ranjan Das
Journal:  J Glob Infect Dis       Date:  2019-11-26

7.  Unusual rotavirus genotypes in humans and animals with acute diarrhoea in Northeast India.

Authors:  P Chakraborty; M J Bhattacharjee; I Sharma; P Pandey; N N Barman
Journal:  Epidemiol Infect       Date:  2016-04-26       Impact factor: 4.434

8.  Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: A Feasibility Study to Integrate Two Surveillance Systems.

Authors:  Arif Mohammad Tanmoy; Asm Nawshad Uddin Ahmed; Rajesh Arumugam; Belal Hossain; Mahfuza Marzan; Shampa Saha; Shams El Arifeen; Abdullah H Baqui; Robert E Black; Gagandeep Kang; Samir Kumar Saha
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

9.  The prevalence and genotype distribution of rotavirus A infection among children with acute gastroenteritis in Kunming, China.

Authors:  Ziqin Dian; Mao Fan; Binghui Wang; Yue Feng; Hao Ji; Shuwei Dong; A-Mei Zhang; Li Liu; Hua Niu; Xueshan Xia
Journal:  Arch Virol       Date:  2016-10-07       Impact factor: 2.574

10.  Quantification of Rotavirus Diarrheal Risk Due to Hydroclimatic Extremes Over South Asia: Prospects of Satellite-Based Observations in Detecting Outbreaks.

Authors:  M Alfi Hasan; Colleen Mouw; Antarpreet Jutla; Ali S Akanda
Journal:  Geohealth       Date:  2018-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.